D. Narayanan's Profile

Role	Title	Level	Year	L/R
🐜	Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics. 7 auth. S. Narayanan, M. Pavithran, Aiswarya Viswanath, D. Narayanan, C. C. Mohan, K. Manzoor, ... D. Menon	6	2014	6 🐜
🦁	Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug Ibuprofen-Sodium: an in vitro and in vivo analysis. D. Narayanan, Geena M G, L. H., Manzoor Koyakutty, S. Nair, D. Menon	6	2013	6 🦁
🐜	Hematotoxicological analysis of surface-modified and -unmodified chitosan nanoparticles. 8 auth. Ragima Nadesh, D. Narayanan, Sreerekha P R, Sajini Vadakumpully, U. Mony, Manzoor Koyakkutty, ... S. Nair, D. Menon	5	2013	5 🐜
🦁	A systematic evaluation of hydroxyethyl starch as a potential nanocarrier for parenteral drug delivery. D. Narayanan, S. Nair, D. Menon	5	2015	5 🦁
🦁	Cardiac Spectrum, Cytogenetic Analysis and Thyroid Profile of 418 Children with Down Syndrome from South India: A Cross-sectional Study 11 auth. D. Narayanan, Dhanya Yesodharan, M. Kappanayil, Shwetha Kuthiroly, M. Thampi, Zareena V Hamza, ... A. Anilkumar, K. M. Nair, K. Sundaram, R. Kumar, S. Nampoothiri	4	2014	4 🦁
🐜	Exome sequencing for perinatal phenotypes: The significance of deep phenotyping 8 auth. S. Aggarwal, V. S. Vineeth, A. Das Bhowmik, A. Tandon, Aditya D. Kulkarni, D. Narayanan, ... Amrita Bhattacherjee, A. Dalal	4	2019	4 🐜
🦁	Computer-aided Facial Analysis in Diagnosing Dysmorphic Syndromes in Indian Children D. Narayanan, P. Ranganath, S. Aggarwal, A. Dalal, S. Phadke, K. Mandal	4	2019	4 🦁
🐜	Locus and allelic heterogeneity and phenotypic variability in Waardenburg syndrome 13 auth. Puneeth H. Somashekar, K. Girisha, S. Nampoothiri, K. Gowrishankar, R. Devi, Neerja Gupta, D. Narayanan, A. Kaur, S. Bajaj, S. Jagadeesh, ... L. Lewis, S. Shailaja, A. Shukla	4	2018	4 🐜